Report Claims Doctors Misuse Medical Codes to Bypass Bans on Transgender Procedures

Doctors may be using fraudulent medical codes to conceal transgender procedures from insurance companies and regulators, according to a report from the medical watchdog group Do No Harm. This practice could allow healthcare providers to bypass state bans on certain interventions, including genital surgeries and hormone treatments for minors. The implications of such actions raise significant ethical concerns regarding patient safety and regulatory oversight.

Explainer As A Former DC Cop, The Federal Takeover Was The Right Move

The core issue revolves around the ethical implications of using misleading coding practices to facilitate potentially irreversible medical procedures for children. Critics argue that this undermines regulatory oversight and patient safety, while supporters of gender-affirming care maintain that such interventions are necessary for the well-being of transgender youth. The report details how healthcare providers can use generic endocrine care codes as substitutes for gender-affirming treatments, enabling both the administration of these procedures and financial reimbursement. Kurt Miceli, chief medical officer at Do No Harm, stated, "Medical diagnosis codes are being subverted by gender ideologues to avoid proper reporting, hide their activism from scrutiny, and enable potentially fraudulent billing practices."

Coding Practices Under Scrutiny

Healthcare providers utilize ICD-10-CM (International Classification of Diseases) diagnosis codes for medical billing and data reporting. These codes help organizations like the Centers for Disease Control and Prevention (CDC) track the prevalence of various health conditions. However, the report claims that some doctors are misusing these codes to obscure the nature of the treatments being provided. Miceli emphasized the need for increased regulatory oversight, noting that the current system allows for potential misuse. "By hiding transgender procedures behind codes meant for other conditions, providers are — at minimum — skirting guidelines and ethical standards," he said.

The report cites evidence that suggests some doctors are using misleading coding to bypass protections against administering these interventions to minors. For instance, it highlights cases where prescriptions for testosterone were filled shortly after office visits without appropriate diagnosis codes, raising concerns about the legitimacy of the coding practices. Such actions could potentially endanger the health and safety of vulnerable populations, particularly minors who may not fully understand the implications of these medical interventions.

Evidence of Misuse

The report identifies specific ICD-10 codes that may be used to disguise child transition interventions from insurers and regulators. These include codes for endocrine disorders and hormone replacement therapy. The findings suggest that some medical professionals may be intentionally misrepresenting the nature of the treatments to secure insurance reimbursement. Concerns about the misuse of medical coding are not unfounded, as major medical organizations involved in gender-affirming care have reportedly acknowledged the use of these misleading codes. According to the report, training materials from the World Professional Association for Transgender Health (WPATH) have endorsed the application of endocrine-related ICD-10 codes for sex change treatments and insurance reimbursement.

The Campaign for Southern Equality has also published guidance that encourages the use of alternative coding to avoid scrutiny regarding sex-denying medical interventions. This guidance has reportedly been removed from public view since March 2025, following changes in the political landscape. The removal of such guidance raises questions about transparency and accountability in medical coding practices, especially in a politically charged environment.

Responses and Reactions

While the report raises significant ethical questions, it is important to note that advocates for gender-affirming care argue that these treatments are essential for the mental health and well-being of transgender youth. Supporters assert that the procedures can alleviate gender dysphoria and improve quality of life for affected individuals. However, they did not respond directly to the specific allegations made in the report, leaving some questions unanswered.

Planned Parenthood of Southeastern Pennsylvania has stated that it uses endocrine disorder codes to meet the needs of most insurance companies and patients, indicating that the use of such codes is not uncommon in the field. This statement suggests that while the practices may be controversial, they are also part of a broader trend in healthcare where coding practices adapt to meet the needs of patients and insurers alike.

The ongoing debate surrounding transgender healthcare for minors continues to evoke strong opinions on both sides, with calls for greater transparency and accountability in medical practices. As the landscape evolves, the implications of these findings may lead to increased scrutiny of coding practices and regulatory measures in the healthcare system. The intersection of medical ethics, patient safety, and regulatory compliance remains a critical area of concern as stakeholders navigate the complexities of transgender healthcare.